These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 38473212)

  • 21. Pilot study of gene mutations associated with Lynch syndrome in Slovak patients with breast cancer.
    Krasničanová L; Saade R; Priščáková P; Gbelcová H; Kaľavská K; Karaba M; Benca J; Mego M; Repiská V
    Klin Onkol; 2023; 36(2):130-134. PubMed ID: 37072247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study.
    Bucksch K; Zachariae S; Aretz S; Büttner R; Holinski-Feder E; Holzapfel S; Hüneburg R; Kloor M; von Knebel Doeberitz M; Morak M; Möslein G; Nattermann J; Perne C; Rahner N; Schmiegel W; Schulmann K; Steinke-Lange V; Strassburg CP; Vangala DB; Weitz J; Loeffler M; Engel C;
    BMC Cancer; 2020 May; 20(1):460. PubMed ID: 32448342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population.
    Cenin DR; Naber SK; Lansdorp-Vogelaar I; Jenkins MA; Buchanan DD; Preen DB; Ee HC; O'Leary P
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1737-1744. PubMed ID: 29645364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PREMM5 distinguishes sporadic from Lynch syndrome-associated MMR-deficient/MSI-high colorectal cancer.
    Sandoval RL; Horiguchi M; Ukaegbu C; Furniss CS; Uno H; Syngal S; Yurgelun MB
    Fam Cancer; 2023 Oct; 22(4):459-465. PubMed ID: 37572151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenic Insights into DNA Mismatch Repair (MMR) Genes-Proteins and Microsatellite Instability: Focus on Adrenocortical Carcinoma and Beyond.
    Carsote M; Turturea IF; Turturea MR; Valea A; Nistor C; Gheorghisan-Galateanu AA
    Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor Testing and Genetic Analysis to Identify Lynch Syndrome Patients in an Italian Colorectal Cancer Cohort.
    Pantaleo A; Forte G; Cariola F; Valentini AM; Fasano C; Sanese P; Grossi V; Buonadonna AL; De Marco K; Lepore Signorile M; Guglielmi AF; Manghisi A; Gigante G; Armentano R; Disciglio V; Simone C
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rates and outcomes of testing for lynch syndrome in a national colorectal cancer screening programme.
    Cudmore J; Kumar L; O'Moráin N; Cullen G; Horgan G; Aird J; Sheahan K; Winter DC; Kennelly R; Leyden J
    Cancer Epidemiol; 2023 Feb; 82():102314. PubMed ID: 36608496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer.
    Li Y; Fan L; Zheng J; Nie X; Sun Y; Feng Q; Lian S; Bai W; Cai W; Yang Y; Su B; Xi Y; Lin D
    Cancer Biol Med; 2022 Jun; 19(8):1235-48. PubMed ID: 35638907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lynch Syndrome: From Carcinogenesis to Prevention Interventions.
    Gambini D; Ferrero S; Kuhn E
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical problems of colorectal cancer and endometrial cancer cases with unknown cause of tumor mismatch repair deficiency (suspected Lynch syndrome).
    Buchanan DD; Rosty C; Clendenning M; Spurdle AB; Win AK
    Appl Clin Genet; 2014; 7():183-93. PubMed ID: 25328415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discordant DNA mismatch repair protein status between synchronous or metachronous gastrointestinal carcinomas: frequency, patterns, and molecular etiologies.
    Vyas M; Firat C; Hechtman JF; Weiser MR; Yaeger R; Vanderbilt C; Benhamida JK; Keshinro A; Zhang L; Ntiamoah P; Gonzalez M; Andrade R; El Dika I; Markowitz AJ; Smith JJ; Garcia-Aguilar J; Vakiani E; Klimstra DS; Stadler ZK; Shia J
    Fam Cancer; 2021 Jul; 20(3):201-213. PubMed ID: 33033905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mismatch-repair deficiency, microsatellite instability, and lynch syndrome in ovarian cancer: A systematic review and meta-analysis.
    Mitric C; Salman L; Abrahamyan L; Kim SR; Pechlivanoglou P; Chan KKW; Gien LT; Ferguson SE
    Gynecol Oncol; 2023 Mar; 170():133-142. PubMed ID: 36682091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implication of DNA repair genes in Lynch-like syndrome.
    Xicola RM; Clark JR; Carroll T; Alvikas J; Marwaha P; Regan MR; Lopez-Giraldez F; Choi J; Emmadi R; Alagiozian-Angelova V; Kupfer SS; Ellis NA; Llor X
    Fam Cancer; 2019 Jul; 18(3):331-342. PubMed ID: 30989425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diverse molecular profiles of lynch syndrome-associated colorectal cancers are (highly) dependent on underlying germline mismatch repair mutations.
    Helderman NC; Bajwa-Ten Broeke SW; Morreau H; Suerink M; Terlouw D; van der Werf-' T Lam AS; van Wezel T; Nielsen M
    Crit Rev Oncol Hematol; 2021 Jul; 163():103338. PubMed ID: 34044097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lynch syndrome: from detection to treatment.
    Williams MH; Hadjinicolaou AV; Norton BC; Kader R; Lovat LB
    Front Oncol; 2023; 13():1166238. PubMed ID: 37197422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The contribution of Lynch syndrome to early onset malignancy in Ireland.
    Talbot A; O'Donovan E; Berkley E; Nolan C; Clarke R; Gallagher D
    BMC Cancer; 2021 May; 21(1):617. PubMed ID: 34039291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm.
    Everett JN; Raymond VM; Dandapani M; Marvin M; Kohlmann W; Chittenden A; Koeppe E; Gustafson SL; Else T; Fullen DR; Johnson TM; Syngal S; Gruber SB; Stoffel EM
    JAMA Dermatol; 2014 Dec; 150(12):1315-21. PubMed ID: 25006859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of suspected Lynch syndrome patients carrying BRCA and BRCA-like variants with Lynch syndrome probands: Phenotypic characteristics and pedigree analyses.
    Xu Y; Li C; Wang Z; Liu F; Xu Y
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1359. PubMed ID: 32548945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Tumor Mutation Burden Analysis in Detecting Lynch Syndrome in Precision Medicine: Analysis of 2,501 Japanese Cancer Patients.
    Kiyozumi Y; Matsubayashi H; Higashigawa S; Horiuchi Y; Kado N; Hirashima Y; Shiomi A; Oishi T; Ohnami S; Ohshima K; Urakami K; Nagashima T; Yamaguchi K
    Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):166-174. PubMed ID: 33046448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endometrial cancer in Lynch syndrome.
    Zhao S; Chen L; Zang Y; Liu W; Liu S; Teng F; Xue F; Wang Y
    Int J Cancer; 2022 Jan; 150(1):7-17. PubMed ID: 34398969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.